Thursday, May 14, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

Healthcare Shrinkage

Healthcare's entering a period of contraction

Jay K Joshi by Jay K Joshi
February 27, 2024
in Trends
0
Healthcare Shrinkage

Cihat Hidir

Healthcare is many things to many people but we all think that it’s on a never-ending growth trajectory. More hospitals, more buildings, more mergers and acquisitions – more of everything it seems. Well, like many things in medicine, this pretense of growth isn’t what it initially appears to be. Healthcare is slowly entering the early phases of a period of contraction.

There are a few early tells. To notice them, you have to recognize how change occurs in healthcare. Hint: Follow the flow of money. But not just the money itself, but how the money interacts with the practice of clinical care. The way that those interactions change portends much of how healthcare will change.

In recent years, prior authorization denials and the subsequent denials of appeals have increased. It’s something you wouldn’t notice unless you’re a health policy wonk and you actively stay abreast of these things – or, more pertinently, if you’re a patient noticing the decreasing coverage. However, the increase in denials is a major bellwether: It signals how healthcare administrative bloat will drive cost-cutting measures.

Health insurance entities have refined bureaucratic paperwork down to a science. If they want to limit reimbursements for a particular clinical service or treatment, they’ll add prior authorization documentation requirements and eventually increase the denial rates in short order. They won’t change their coverage scheme clinically, but they’ll make it harder to obtain coverage, and thereby adjust their bottom line through the pretense of clinical documentation paperwork.

The bureaucratic overload will increase. It’ll look like growth. But the bottom line will decrease. It sounds counterintuitive. A larger bureaucracy normally means a larger overhead, which would imply growth under normal circumstances. But this is just a sleight of hand. See healthcare can’t contract like other industries. There’s too much at stake politically.

When a hospital lays off staff, the protests begin, and the political capital vanishes. So to save face, and to contract at the same time, the health industry has device a unique model of using bureaucratic angst as a cost cutting measure.

As a result, health insurance entities don’t have to dole out as much per patient financially while avoiding the impression that they’re inadequately providing coverage. And, of course, then hospitals can justify charging patients without incurring any political backlash.

It’s hard to notice at first, but if you’re keenly watching, you’ll see it everywhere. It’s already quite apparent to patients struggling with mounting medical debt. Where do you think all that debt came from? Denial of coverage means less money out of the pockets of insurance companies and more out of the pockets of patients.

It’s part of a broader cost cutting shift in healthcare that places more financial burden on patients. And it’s disguised through a veil of clinical oversight. Hospitals and insurance entities aren’t overtly denying care to patients. They’re just making it harder to justify coverage for that care. But, regardless of what the payer system algorithm calculates, that care is still needed. So the costs come out of the pocket of patients.

This is a reaction to the unprecedented growth of healthcare in recent decades. Since the late twentieth century, healthcare in the United States has enjoyed incredible growth, incredible technological developments, and life-altering breakthroughs. It was all subsidized by a health system that depended on a fast charging American economy.

Now with the economy slowing, healthcare faces unique financial pressures. But it can’t just contract or enforce traditional cost cutting measures. It has to bloat administratively before it collapses on itself like a decaying star that’s not big enough to explode into a supernova.

The key factor to look out for is: How do changes in clinical care, or more specifically, what aspects of care that can be defined through documentation, coding schedules, protocols and procedures – things that matter to the health payers and other the financial intermediaries – affect the patient financially? The answer’s not always immediately apparent.

Healthcare entities that run modern medicine never directly reveal their true intention. It’s always seen through a fog of war – carefully revealing select things at select times. So the next time you see a new agency or a new action committee, just remember, that bloat’s just the canary in the coalmine for healthcare’s pending period of contraction.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Joshi is the founding editor of Daily Remedy.

Comments 0

  1. Brian Lynch says:
    2 years ago

    Yep

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The 340B Coalition

    The 340B Coalition

    0 shares
    Share 0 Tweet 0
  • The Number Nobody Publishes

    0 shares
    Share 0 Tweet 0
  • How Smart Kitchen Renovations Support Healthy Habits and Wellness

    0 shares
    Share 0 Tweet 0
  • Force of Impact in a Tackle

    0 shares
    Share 0 Tweet 0
  • The Biosimilar That Wouldn’t

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy